focus -WSS

focus

author：comprehensive 2025-10-01 00:16:52 - browse：8628

Empty biotech lab with no people and green benches and cabinets. -- biotech coverage from STAT — Adobe

Demand for new lab space has plummeted by more than half since the end of 2021, and life science vacancy rates are the highest they’ve been in a decade amid the biotech industry’s ongoing downturn, according to a report released Tuesday by Jones Lang LaSalle, a commercial real estate services company

Tenant demand, measured by the total amount of new space that companies are looking to lease, dropped from 25.3 million square feet at the end of 2021 to 10.1 million square feet by the second quarter of this year across eight top life science markets: Boston, the Bay Area, San Diego, Raleigh-Durham, Philadelphia, Seattle, Los Angeles, and the Washington, D.C., area.

The real estate numbers presented in JLL’s annual life sciences report are yet another sign that the biotech industry, which outperformed the broader market for years, is in the midst of a slowdown. Lab space is increasingly going unused amid a supply glut, and more companies are looking to sublease space. Real estate observers say there are some signs these trends could turn around in the next year or two, though that is far from certain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Novo Nordisk touts Wegovy study, but still struggling with supply

explore

WSS

Maui wildfire now ranks as the fifth

Meta's Zuckerberg and Chan on track to put $50 billion into science

Biden administration begins canceling student loan debt for 804,000 borrowers

Meta's Zuckerberg and Chan on track to put $50 billion into science

First Opinion Podcast: How to protect health care in times of war

Traditional Chinese medicine benefits explored in new JAMA study

knowledge

focus

focus

Jerome Adams on the need for new antivirals for Covid

Megan Rapinoe shares emotional post following US Women's World Cup exit

Medicare details structure of new drug price negotiation program

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

Affirmative action in medical school literally saved lives

Readout Newsletter: What happened with Sarepta's Duchenne data

BioMarin wins approval for gene therapy to treat hemophilia A

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Malaria cases in Florida and Texas: Here’s what you need to know

Treatments for cramps don't cut it. Why aren't there better options?

focus

Illumina slashes 2023 revenue projections yet again

Maker of FluMist seeks to allow at

Judge sides with young activists in first

Schizophrenia gene found to be linked to cells' energy dysfunction

Biden's order seeks to regulate AI risk without stifling innovation

The FDA weighs the risks of candy

hotspot

explore

hotspot

explore